Management of intra-aortic balloon counterpulsation by argatroban anticoagulation in a patient with a history of heparin-induced thrombocytopenia
Noriaki Tabata(Kumamoto University), Hisao Ogawa(Kumamoto University Hospital), Tomoko Tanaka(Kumamoto University), Eiichiro Yamamoto(Sapporo Medical University), Seiji Hokimoto(Kumamoto University), Seigo Sugiyama(Diabetes Care Center), Koichi Kaikita(Kumamoto University), Kyoko Hirakawa(Kumamoto University), Megumi Yamamuro(IRYO Sosei University), Michio Mizobe(Kumamoto University), Shinji Tayama(Saiseikai Kumamoto Hospital), Kenichi Tsujita(Kumamoto University)
Cited by 4
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755